血漿療法は、欠乏または不足しているタンパク質を補充することによって人々が健康で快適な生活を送ることを可能にします。血漿分画技術の増加によって、ヒトの血液は、衰弱性、慢性、および生命を脅かす疾患のための血漿由来の治療法を生み出しています。血漿製剤は、治療と予防において重要な役割を果たします。血漿製剤は、出血の緊急事態、自己免疫疾患、および血友病、先天性および後天性免疫不全を含む多くの慢性疾患を管理するために不可欠です。医療へのアクセスおよび新規製品や用途の拡大、診断の進歩などが、血漿療法市場の成長を後押しします。Plasma Protein Therapeutics Associationによると、2017年における世界最大の血漿供給源となった地域は米国でした。有利な規制ガイドラインがドナーの数を増やし、効率的な血漿採取インフラが世界中の血漿療法市場をけん引しています。
COVID-19のパンデミックの発生は、感染の蔓延を防ぐために政府が発出したロックダウンと共に、様々な業種に影響を与えました。感染した患者の数の急増と比較して、スタッフと資源が不足したことから、感染した患者の増加が病院の管理に影響を与え、医療処置と手術に遅れが生じました。非緊急医療処置は延期され、患者に影響を及ぼしたり、実行されなかった場合に人命を失う可能性のある緊急処置が優先されました。
COVID-19のパンデミックは、血漿の供給に更なる圧力をかけました。アジア経済における多血小板血漿（PRP）製剤の企業、サプライヤー、および事業者は、COVID-19患者の急増によって影響を受けました。T中低所得国は、医療インフラの不備や、政府が業界やサプライヤーに課している規制によって課題に直面しました。パンデミックの間、ワクチン、他の特定の治療薬および治療法がないため、治療のために血漿療法が提案されました。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL PLASMA THERAPY MARKET, BY TYPE
6.1. Introduction
6.2. Pure Plasma Rich Protein (PRP)
6.3. Leukocyte-Rich PRP
6.4. Pure Platelet-Rich Fibrin
6.5. Leukocyte-Rich Fibrin
7. GLOBAL PLASMA THERAPY MARKET, BY SOURCE
7.1. Introduction
7.2. Autologous
7.3. Allogenic
8. GLOBAL PLASMA THERAPY MARKET, BY APPLICATION
8.1. Introduction
8.2. Orthopedic
8.3. Dermatology
8.4. Cardiac Muscle Injury
8.5. Dental
8.6. Nerve Injury
9. GLOBAL PLASMA THERAPY MARKET, BY END USER
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Research Institutes
10. GLOBAL PLASMA THERAPY MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. Market Size & Estimates, by Country, 2018-2030
10.2.2. Market Size & Estimates, by Type, 2018-2030
10.2.3. Market Size & Estimates, by Source, 2018-2030
10.2.4. Market Size & Estimates, by Application, 2018-2030
10.2.5. Market Size & Estimates, by End User, 2018-2030
10.2.6. US
10.2.6.1. Market Size & Estimates, by Type, 2018-2030
10.2.6.2. Market Size & Estimates, by Source, 2018-2030
10.2.6.3. Market Size & Estimates, by Application, 2018-2030
10.2.6.4. Market Size & Estimates, by End User, 2018-2030
10.2.7. Canada
10.2.7.1. Market Size & Estimates, by Type, 2018-2030
10.2.7.2. Market Size & Estimates, by Source, 2018-2030
10.2.7.3. Market Size & Estimates, by Application, 2018-2030
10.2.7.4. Market Size & Estimates, by End User, 2018-2030
10.3. Europe
10.3.1. Market Size & Estimates, by Country, 2018-2030
10.3.2. Market Size & Estimates, by Type, 2018-2030
10.3.3. Market Size & Estimates, by Source, 2018-2030
10.3.4. Market Size & Estimates, by Application, 2018-2030
10.3.5. Market Size & Estimates, by End User, 2018-2030
10.3.6. Germany
10.3.6.1. Market Size & Estimates, by Type, 2018-2030
10.3.6.2. Market Size & Estimates, by Source, 2018-2030
10.3.6.3. Market Size & Estimates, by Application, 2018-2030
10.3.6.4. Market Size & Estimates, by End User, 2018-2030
10.3.7. France
10.3.7.1. Market Size & Estimates, by Type, 2018-2030
10.3.7.2. Market Size & Estimates, by Source, 2018-2030
10.3.7.3. Market Size & Estimates, by Application, 2018-2030
10.3.7.4. Market Size & Estimates, by End User, 2018-2030
10.3.8. UK
10.3.8.1. Market Size & Estimates, by Type, 2018-2030
10.3.8.2. Market Size & Estimates, by Source, 2018-2030
10.3.8.3. Market Size & Estimates, by Application, 2018-2030
10.3.8.4. Market Size & Estimates, by End User, 2018-2030
10.3.9. Italy
10.3.9.1. Market Size & Estimates, by Type, 2018-2030
10.3.9.2. Market Size & Estimates, by Source, 2018-2030
10.3.9.3. Market Size & Estimates, by Application, 2018-2030
10.3.9.4. Market Size & Estimates, by End User, 2018-2030
10.3.10. Spain
10.3.10.1. Market Size & Estimates, by Type, 2018-2030
10.3.10.2. Market Size & Estimates, by Source, 2018-2030
10.3.10.3. Market Size & Estimates, by Application, 2018-2030
10.3.10.4. Market Size & Estimates, by End User, 2018-2030
10.3.11. Rest of Europe
10.3.11.1. Market Size & Estimates, by Type, 2018-2030
10.3.11.2. Market Size & Estimates, by Source, 2018-2030
10.3.11.3. Market Size & Estimates, by Application, 2018-2030
10.3.11.4. Market Size & Estimates, by End User, 2018-2030
10.4. Asia-Pacific
10.4.1. Market Size & Estimates, by Country, 2018-2030
10.4.2. Market Size & Estimates, by Type, 2018-2030
10.4.3. Market Size & Estimates, by Source, 2018-2030
10.4.4. Market Size & Estimates, by Application, 2018-2030
10.4.5. Market Size & Estimates, by End User, 2018-2030
10.4.6. China
10.4.6.1. Market Size & Estimates, by Type, 2018-2030
10.4.6.2. Market Size & Estimates, by Source, 2018-2030
10.4.6.3. Market Size & Estimates, by Application, 2018-2030
10.4.6.4. Market Size & Estimates, by End User, 2018-2030
10.4.7. Japan
10.4.7.1. Market Size & Estimates, by Type, 2018-2030
10.4.7.2. Market Size & Estimates, by Source, 2018-2030
10.4.7.3. Market Size & Estimates, by Application, 2018-2030
10.4.7.4. Market Size & Estimates, by End User, 2018-2030
10.4.8. India
10.4.8.1. Market Size & Estimates, by Type, 2018-2030
10.4.8.2. Market Size & Estimates, by Source, 2018-2030
10.4.8.3. Market Size & Estimates, by Application, 2018-2030
10.4.8.4. Market Size & Estimates, by End User, 2018-2030
10.4.9. South Korea
10.4.9.1. Market Size & Estimates, by Type, 2018-2030
10.4.9.2. Market Size & Estimates, by Source, 2018-2030
10.4.9.3. Market Size & Estimates, by Application, 2018-2030
10.4.9.4. Market Size & Estimates, by End User, 2018-2030
10.4.10. Australia
10.4.10.1. Market Size & Estimates, by Type, 2018-2030
10.4.10.2. Market Size & Estimates, by Source, 2018-2030
10.4.10.3. Market Size & Estimates, by Application, 2018-2030
10.4.10.4. Market Size & Estimates, by End User, 2018-2030
10.4.11. Rest of Asia-Pacific
10.4.11.1. Market Size & Estimates, by Type, 2018-2030
10.4.11.2. Market Size & Estimates, by Source, 2018-2030
10.4.11.3. Market Size & Estimates, by Application, 2018-2030
10.4.11.4. Market Size & Estimates, by End User, 2018-2030
10.5. Rest of the World
10.5.1. Market Size & Estimates, by Country, 2018-2030
10.5.2. Market Size & Estimates, by Type, 2018-2030
10.5.3. Market Size & Estimates, by Source, 2018-2030
10.5.4. Market Size & Estimates, by Application, 2018-2030
10.5.5. Market Size & Estimates, by End User, 2018-2030
10.5.6. Middle East
10.5.6.1. Market Size & Estimates, by Type, 2018-2030
10.5.6.2. Market Size & Estimates, by Source, 2018-2030
10.5.6.3. Market Size & Estimates, by Application, 2018-2030
10.5.6.4. Market Size & Estimates, by End User, 2018-2030
10.5.7. Africa
10.5.7.1. Market Size & Estimates, by Type, 2018-2030
10.5.7.2. Market Size & Estimates, by Source, 2018-2030
10.5.7.3. Market Size & Estimates, by Application, 2018-2030
10.5.7.4. Market Size & Estimates, by End User, 2018-2030
10.5.8. Latin America
10.5.8.1. Market Size & Estimates, by Type, 2018-2030
10.5.8.2. Market Size & Estimates, by Source, 2018-2030
10.5.8.3. Market Size & Estimates, by Application, 2018-2030
10.5.8.4. Market Size & Estimates, by End User, 2018-2030
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. Key Players Market Share Analysis, 2020 (%)
11.3. Competitive Benchmarking
11.4. Competitor Dashboard
11.5. Major Growth Strategy in the Market
11.6. Key Developments & Growth Strategies
11.6.1. Product Developments
11.6.2. Mergers & Acquisitions
11.6.3. Contracts & Agreements
12. COMPANY PROFILES
12.1. BioLife Plasma Services (US)
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Software/Solutions Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Cambryn Biologics LLC (US)
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Software/Solutions Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Biotest (Germany)
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Software/Solutions Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.4. CSL Ltd. (Australia)
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Software/Solutions Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Grifols International S.A. (Spain)
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Software/Solutions Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Kedrion S.p.A. (Italy)
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Software/Solutions Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. LFB S.A (France)
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Software/Solutions Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Bio Products Laboratory Ltd. (U.K.)
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Software/Solutions Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. China Biologic Products, Inc. (China)
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Software/Solutions Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Octapharma (Switzerland)
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Software/Solutions Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Arthrex, Inc. (US)
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Software/Solutions Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. DePuy Synthes Companies (US)
12.12.1. Company Overview
12.12.2. Financial Overview
12.12.3. Software/Solutions Offered
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. Grifols S.A (Spain)
12.13.1. Company Overview
12.13.2. Financial Overview
12.13.3. Software/Solutions Offered
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. Global Stem Cells Group, Inc. (US)
12.14.1. Company Overview
12.14.2. Financial Overview
12.14.3. Software/Solutions Offered
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.14.6. Key Strategies
12.15. Juventix Regenerative Medical LLC (U.S.)
12.15.1. Company Overview
12.15.2. Financial Overview
12.15.3. Software/Solutions Offered
12.15.4. Key Developments
12.15.5. SWOT Analysis
12.15.6. Key Strategies
12.16. Celling Biosciences, Inc. (U.S.)
12.16.1. Company Overview
12.16.2. Financial Overview
12.16.3. Software/Solutions Offered
12.16.4. Key Developments
12.16.5. SWOT Analysis
12.16.6. Key Strategies
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 3 GLOBAL PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL PLASMA THERAPY MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 7 NORTH AMERICA PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8 NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 9 NORTH AMERICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 10 NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11 NORTH AMERICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 12 US PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13 US PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 14 US PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15 US PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16 CANADA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17 CANADA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 18 CANADA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19 CANADA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20 EUROPE PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21 EUROPE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22 EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 23 EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24 EUROPE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25 GERMANY PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26 GERMANY PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 27 GERMANY PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28 GERMANY PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29 FRANCE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30 FRANCE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 31 FRANCE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32 FRANCE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33 UK PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34 UK PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 35 UK PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36 UK PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37 ITALY PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38 ITALY PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 39 ITALY PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40 ITALY PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41 SPAIN PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42 SPAIN PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 43 SPAIN PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44 SPAIN PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45 REST OF EUROPE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46 REST OF EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 47 REST OF EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48 REST OF EUROPE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51 ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52 ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53 ASIA-PACIFIC PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54 CHINA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55 CHINA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56 CHINA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57 CHINA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58 INDIA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59 INDIA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60 INDIA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61 INDIA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62 JAPAN PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63 JAPAN PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64 JAPAN PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65 JAPAN PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66 AUSTRALIA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67 AUSTRALIA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68 AUSTRALIA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69 AUSTRALIA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70 SOUTH KOREA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71 SOUTH KOREA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72 SOUTH KOREA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73 SOUTH KOREA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78 REST OF THE WORLD PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79 REST OF THE WORLD PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80 REST OF THE WORLD PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81 REST OF THE WORLD PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82 REST OF THE WORLD PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83 MIDDLE EAST PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84 MIDDLE EAST PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85 MIDDLE EAST PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86 MIDDLE EAST PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87 AFRICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88 AFRICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89 AFRICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90 AFRICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91 LATIN AMERICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92 LATIN AMERICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93 LATIN AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94 LATIN AMERICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 GLOBAL PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 5 GLOBAL PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 6 GLOBAL PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 7 GLOBAL PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 8 GLOBAL PLASMA THERAPY MARKET, BY REGION, 2018-2030 (USD MILLION)
FIGURE 9 NORTH AMERICA PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
FIGURE 10 NORTH AMERICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 11 NORTH AMERICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 12 NORTH AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 13 NORTH AMERICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 14 US PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 15 US PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 16 US PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 17 US PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 18 CANADA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 19 CANADA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 20 CANADA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 21 CANADA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 22 EUROPE PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
FIGURE 23 EUROPE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 24 EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 25 EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 26 EUROPE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 27 GERMANY PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 28 GERMANY PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 29 GERMANY PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 30 GERMANY PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 31 FRANCE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 32 FRANCE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 33 FRANCE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 34 FRANCE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 35 UK PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 36 UK PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 37 UK PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 38 UK PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 39 ITALY PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 40 ITALY PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 41 ITALY PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 42 ITALY PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 43 SPAIN PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 44 SPAIN PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 45 SPAIN PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 46 SPAIN PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 47 REST OF EUROPE PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 48 REST OF EUROPE PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 49 REST OF EUROPE PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 50 REST OF EUROPE PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 51 ASIA-PACIFIC PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
FIGURE 52 ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 53 ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 54 ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 55 ASIA-PACIFIC PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 56 CHINA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 57 CHINA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 58 CHINA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 59 CHINA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 60 INDIA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 61 INDIA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 62 INDIA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 63 INDIA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 64 JAPAN PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 65 JAPAN PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 66 JAPAN PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 67 JAPAN PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 68 AUSTRALIA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 69 AUSTRALIA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 70 AUSTRALIA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 71 AUSTRALIA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 72 SOUTH KOREA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 73 SOUTH KOREA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 74 SOUTH KOREA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 75 SOUTH KOREA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 76 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 77 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 78 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 79 REST OF ASIA-PACIFIC PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 80 REST OF THE WORLD PLASMA THERAPY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
FIGURE 81 REST OF THE WORLD PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 82 REST OF THE WORLD PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 83 REST OF THE WORLD PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 84 REST OF THE WORLD PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 85 MIDDLE EAST PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 86 MIDDLE EAST PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 87 MIDDLE EAST PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 88 MIDDLE EAST PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 89 AFRICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 90 AFRICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 91 AFRICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 92 AFRICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
FIGURE 93 LATIN AMERICA PLASMA THERAPY MARKET, BY TYPE, 2018-2030 (USD MILLION)
FIGURE 94 LATIN AMERICA PLASMA THERAPY MARKET, BY SOURCE, 2018-2030 (USD MILLION)
FIGURE 95 LATIN AMERICA PLASMA THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
FIGURE 96 LATIN AMERICA PLASMA THERAPY MARKET, BY END-USER, 2018-2030 (USD MILLION)
